Cadrenal Therapeutics (CVKD)

• Market cap: $28M
• 1 day: 5.73%
• 5 days: -2.22%
• 1 month: -1.23%
• 3 months: 31.09%
• 6 months: -16.81%
• Year to date: -11.87%
• 1 year: -19.46%
• 5 years: -77.9%
• 10 years: -77.9%
• Sector: Healthcare
• Industry: Biotechnology

About: Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

Employees: 4